변자민 (서울대학교병원)님 | 한빛사연구자 > 한빛사

서울대학교병원

최종업데이트 2026.04.01.

Development and multinational validation of a multiple myeloma–specific comorbidity index using real-world cohorts: CAREMM-2108
- Blood Cancer J., 31 March 2026 | https://doi.org/10.1038/s41408-026-01475-1
- 2026-03
- 의약학
- 한빛사논문
Profiling protein-protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemia
- Nat. Biomed. Eng., Jul 18 2024, | https://doi.org/10.1038/s41551-024-01241-3
- 2024-07
- 생명과학
- 한빛사논문
ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma
- npj Precision Onc., 2023 May 20;7(1):46 | https://doi.org/10.1038/s41698-023-00385-w
- 2023-05
- 생명과학
- 한빛사논문
Phase II trial of daratumumab with DCEP in relapsed/refractory multiple myeloma patients with extramedullary disease
- J. Hematol. Oncol., 2022 Oct 23;15(1):150 | doi: 10.1186/s13045-022-01374-5
- 2022-10
- 의약학
- 한빛사논문
Double-stranded RNA induction asa potential dynamic biomarkerfor DNA-demethylating agents
- Mol. Ther.-Nucl. Acids, Volume 29, 13 September 2022, Pages 370-383 | https://doi.org/10.1016/j.omtn.2022.07.014
- 2022-09
- 생명과학
- 한빛사논문

연구자 ID

저자논문